# OnCo record zyflamend (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/zyflamend/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "zyflamend" ;
  schema:name "Zyflamend (ten-herb formula)"@en ;
  schema:description "Zyflamend is a commercial blend of ten herbs marketed for healthy inflammation and sometimes used by men with prostate cancer. It slowed prostate cancer in animals, but in people there is only a small safety trial in a precancerous prostate condition and a few case reports, which do not show it works."@en ;
  schema:url <https://onco.cc/technologies/zyflamend/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/integrative-medicine/herbs/zyflamend> ;
  onco:status "phase-2" ;
  onco:tag "complementary", "supportive-care", "evidence:insufficient" ;
  onco:related <https://onco.cc/technologies/curcumin-turmeric/>, <https://onco.cc/technologies/ginger-nausea/>, <https://onco.cc/technologies/beta-elemene/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/dietary-supplements-treatment-interactions/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/bicalutamide/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> .